Ptor TANK with all the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J Biol Chem 2002; 277: 370297036. 42. Leonardi A, Chariot A, Claudio E, Cunningham K, Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA 2000; 97: 104940499. 43. Robert I, Aussems M, Keutgens A, Zhang X, Hennuy B, Viatour P et al. Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein includes the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene 2009; 28: 1626638. 44. Keutgens A, Zhang X, Shostak K, Robert I, Olivier S, Vanderplasschen A et al. BCL-3 degradation includes its polyubiquitination by means of a FBW7-independent pathway and its binding towards the proteasome subunit PSMB1. J Biol Chem 2010; 285: 258315840.1. Mandinova A, Lee SW. The p53 pathway as a target in cancer therapeutics: obstacles and guarantee. Sci Transl Med 2011; 3: 64rv61. 2. Vu BT, Vassilev L. Small-molecule inhibitors on the p53-MDM2 interaction. Curr Prime Microbiol Immunol 2011; 348: 15172. 3. Marine JC, Lozano G. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ 2010; 17: 9302. four. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X et al. ERK promotes tumorigenesis by inhibiting FOXO3a through MDM2-mediated degradation. Nat Cell Biol 2008; ten: 13848. five. Kurokawa M, Kim J, Geradts J, Matsuura K, Liu L, Ran X et al. A Network of substrates on the E3 ubiquitin ligases MDM2 and HUWE1 handle apoptosis independently of p53. Sci Signal 2013; 6: ra32. six. Hers I, Vincent EE, Tavare JM. Akt signalling in wellness and illness. Cell Signal 2011; 23: 1515527.Azvudine 7.Elobixibat Manning BD, Cantley LC.PMID:23558135 AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261274. 8. Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008; 27: 5497510. 9. Altomare DA, Testa JR. Perturbations from the AKT signaling pathway in human cancer. Oncogene 2005; 24: 7455464. ten. Manavathi B, Acconcia F, Rayala SK, Kumar R. An inherent function of microtubule network within the action of nuclear receptor. Proc Natl Acad Sci USA 2006; 103: 159815986. 11. Abramovich C, Shen WF, Pineault N, Imren S, Montpetit B, Largman C et al. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA. J Biol Chem 2000; 275: 261726177. 12. Manavathi B, Lo D, Bugide S, Dey O, Imren S, Weiss MJ et al. Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation. J Biol Chem 2012; 287: 5600614. 13. Andjelkovic M, Jakubowicz T, Cron P, Ming XF, Han JW, Hemmings BA. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci USA 1996; 93: 5699704. 14. Gao T, Furnari F, Newton AC. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 2005; 18: 134. 15. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006; 441: 52327. 16. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K et al. Protein phosphatase 2A negatively regulates insulin’s metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 2004; 24: 8778789.
